If your goal is medical weight loss now , four FDA-approved options exist today: Semaglutide (Wegovy, Ozempic) approved for obesity (Wegovy) and type 2 diabetes (Ozempic)
In a randomized, single-blind, 24-week study, participants assigned to dual therapy of 2 mg weekly of the GLP-1 receptor agonist exenatide (Bydureon, AstraZeneca) and 10 mg daily of the SGLT2 inhibitor dapagliflozin (Farxiga, AstraZeneca) lost more weight than those taking either agent alone or those receiving dapagliflozin and metformin extended-release (Xigduo XL, AstraZeneca) or phentermine/topiramate extended-release (Qsymia, Vivus)
Leafy greens are also high in fiber, which supports digestion and balances blood sugar
International sources Some researchers source retatrutide from international suppliers, particularly those based in China where much of the global peptide synthesis capacity is located